The impact of vaccination and coinfection on HPV and cervical cancer

Discrete and Continuous Dynamical Systems - Series B

Volumn 12, Issue 2, 2009, Pages 279-304

  Crawford, Britnee ^a   Zaleta, Christopher M Kribs ^a  

^a UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

Author keywords

Coinfection; HPV; Invasion reproductive number; Vaccination

Indexed keywords

EID: 70349911563     PISSN: 15313492     EISSN: None     Source Type: Journal    
DOI: 10.3934/dcdsb.2009.12.279     Document Type: Conference Paper

References (26)

1. F. X. Bosch, A. Lorincz, N. Munoz, C. J. Meijer and K. V. Shah, The causal relation between human papillomavirus and cervical cancer, Journal of Clinical Pathology, 55 (2002), 244.
2. A. Moscicki, M. Schiffman, S. Kjaer and L. L Villa, Chapter 5: Updating the natural history of hpv and anogenital cancer, Vaccine, 24 S2 (2006), 42-51.
3. M. Rousseau, M. Abrahamowicz, L. L. Villa, M. C. Costa, T. E. Rohan and E. L. Franco, Predictors of cervical coinfection with multiple human papillomavirus types, Cancer Epidemiology, Biomarkers and Prevention, 12 (2003), 1029-1037.
4. M. Rousseau, L. L. Villa, M. C. Costa, M. Abrahamowicz, T. E. Rohan and E. Franco Ocçurrence of cervical infection with multiple human papillomavirus types is associated with age and cytologic abnormalities, Sexually Transmitted Diseases, 30 (2003), 581-587.
5. K. L. Liaw, A. Hildesheim, R. Burk, P. Gravitt, S. Wacholder et al., A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types, Journal of Infectious Diseases, 183 (2001), 8-15.
6. Merck & Co., Inc. GARDASIL [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine] (2006), Merck & Co., Inc, Whitehouse Station, NJ 08889, USA http://www.fda.gov/bbs/topics/news/2006/new01385.html, Access Date 27 October 2008.
7. A. Moscicki, Impact of HP V infection in adolescent populations, Journal of Adolescent Health, 27 (2005), S3-S9.
8. H. Trottier and E. Franco, The epidemiology of genital human papillomavirus infection, Vaccine, 24S1 (2006), 4-15.
9. L. Allen, M. Langlais and C. J. Phillips, The dynamics of two viral infections in a single host population with applications to hantavirus, Mathematical Biosciences, 186 (2003), 191-217.
10. 0 in models for infectious diseases in heterogeneous population, Journal of Mathematical Biology, 28 (1990), 365-382.
11. 0 and its role on global stability, in "Mathematical Approaches for Emerging and Reemerging Infectious Diseases: An Introduction" (eds. Carlos Castillo-Chavez, Sally Blower, Pauline van den Driessche, Denise Kirschner and Abdul-Aziz Yakubu) (IMA Vol. 125), Springer-Verlag, Berlin, (2002), 224-250.
12. U. S. Census Bureau, Table 1: Annual Estimates of the Population by Five-Year Age Groups and Sex for the United States: April 1, 2000 to July 1, 2006 (NC-EST2006-01) (2007), http://www.census.gov/popest/national/asrh/NC- EST2006-sa.html, Access date 25 March 2008.
13. B. Bachtiary, A. Obermair, B. Dreier, P. Birner, G. Breitenecker, T. H. Knocke, E. Selzer and R. Põtter, Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer, International Journal of Cancer, 102 (2002), 237-243.
14. P. Zhang, G. J. Sandland, F. Zhilan, D. Xu and D. J. Minchella, Evolutionary implications for interactions between multiple strains of host and parasite, Journal of Theoretical Biology, 248 (2007), 225-240.
15. T. C. Porco and S. M. Blower, Designing HIV vaccination policies: Subtypes and crossimmunity, Interfaces, 283 (1998), 167-190
16. F. Méndez, N. Muñoz, H. Posso, M. Molano, V. Moreno, A. J. C. van den Bruele, M. Ronderos, C. Meijer and A. Muñoz, Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by hpv vaccines, Journal of Infectious Diseases, 192 (2005), 1158-1165.
17. E. F. Dunne, E. R. Unger, M. Sternberg, et al., Prevalence of HPV infection among females in the United States, Journal of the American Medical Association, 297 (2007), 813-819.
18. A. Green, Y. Nieves, C. Enrigue, C. Kribs-Zaleta and B. Crawford, A cost analysis of human papillomavirus: Individual education vs. mass-media campaign, MTBI Technical Report MTBI-04-03M, Arizona State University 2007.
19. N. Muñoz, F. Méndez, H. Posso, M. Molano, A. J. C. van den Brule, M. Ronderos, C. Meijer and A. Muñoz, Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results, Journal of Infectious Diseases, 190 (2004), 2077-2087.
20. E. H. Elbasha and A. P. Galvani, Vaccination against multiple HPV Types, Mathematical Biosciences, 197 (2005), 88-117.
21. American Cancer Society, Cancer Facts and Figures 2006, 2006, http://www.cancer.org/downloads/STT/CAFF2006PWSecured.pdf, Access date 25 March 2008.
22. M. Nuño, G. Chowell, X. Wang and C. Castillo-Chavez, On the role of cross-immunity and vaccines on the survival of less fit flu strains, Theoretical Population Biology, 71 (2007), 20-29.
23. R. V. Barnabas, P. Laukkanen, P. Koskela, O. Kontula, M. Lehtinen and G. P. Garnett, Epidemiology of HP V 16 and cervical cancer in finald and the potential impact of vaccination: mathematical modelling analyses, PLOS Medicine, 3 (2006), 624-632.
24. Centers for Disease Control and Prevention (CDC), Estimates of Influenza Vaccination Target Population Sizes in 2006 and Recent Vaccine Uptake Levels (2006), http://www.cdc.gov/flu/professionals/vaccination/pdf/targetpopchart.pdf, Access date 25 March 2008.
25. M. J. Khan, P. E. Castle, A. T. Lorincz, S. Wacholder, M. Sherman, D. R. Scott, B. B. Rush, A. G. Glass and M. Schiffman, The elevated 10-year risk of cervical cancer in women with the human papillomavirus (hpv) type 16 or 18 and the possible utility of type-specific hpv testing in clinical practice, Journal of the National Cancer Institute, 97 (2005), 1072-1079.
26. P. Van den Driessche and J. Watmough, Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission, Mathematical Biosciences, 180 (2002), 29-48.